1. Home
  2. CFLT vs PRAX Comparison

CFLT vs PRAX Comparison

Compare CFLT & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

N/A

Current Price

$30.73

Market Cap

7.7B

Sector

Technology

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$308.49

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CFLT
PRAX
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
9.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CFLT
PRAX
Price
$30.73
$308.49
Analyst Decision
Hold
Strong Buy
Analyst Count
28
15
Target Price
$28.73
$572.13
AVG Volume (30 Days)
8.6M
331.9K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
19.63
N/A
EPS
N/A
N/A
Revenue
$1,166,748,000.00
N/A
Revenue This Year
$18.71
N/A
Revenue Next Year
$16.90
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
21.08
N/A
52 Week Low
$15.64
$26.70
52 Week High
$30.81
$354.87

Technical Indicators

Market Signals
Indicator
CFLT
PRAX
Relative Strength Index (RSI) 62.99 43.37
Support Level $30.60 $290.36
Resistance Level $30.76 $322.32
Average True Range (ATR) 0.08 19.36
MACD -0.03 -4.96
Stochastic Oscillator 60.47 26.43

Price Performance

Historical Comparison
CFLT
PRAX

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: